DEM BioPharma
Cambridge
About DEM BioPharma
DEM BioPharma is an immuno-oncology company that is working to eradicate cancer by targeting novel innate immune system checkpoints.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $70.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2022)
- Website: dembiopharma.com
Industries & Categories
Biotechnology, Life Science, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/dem-biopharma-85694 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.